Roche on track for full-year targets – good sales growth in first quarter

In the first three months of 2012 Group sales rose 2% in constant currencies to 11.0 billion Swiss francs. The Pharmaceuticals Division's sales increased 2% to 8.6 billion Swiss francs. Excluding Tami…
Read the full story: Breaking World Pharma News